One-year follow-up in acute stroke patients treated with rtPA in clinical routine

Stroke

Volumn 31, Issue 7, 2000, Pages 1552-1554

  Schmülling, Susanne ^b   Grond, Martin ^b   Rudolf, Jobst ^b   Heiss, Wolf Dieter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

Outcome; Stroke, acute; Thrombolytic therapy; Tissue plasminogen activator

Indexed keywords

ALTEPLASE;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DISABILITY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSIENT ISCHEMIC ATTACK;

EID: 0342322956     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.7.1552     Document Type: Article

References (17)

1. Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke. 1998;29: 1544-1549.
2. The National Institute of Neurological Disorders, and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
3. Kwiatkowski TG, Libmann RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T, for the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med. 1999;340:1781-1787.
4. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason C, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for Healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167-1174.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
6. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J, and the NINDS tPA Stroke Study Group. Improved reliability of the NIH stroke scale using video training. Stroke. 1994;25:2220-2226.
7. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
8. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md Med J. 1965;14:61-65.
9. Shinar D, Gross CR, Bronstein KS, Licata-Gehr EE, Eden DT, Cabrera AR, Fishman IG, Roth AA, Barwick JA, Kunitz SC. Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil. 1987;68:723-728.
10. Korner-Bitensky N, Wood-Dauphinee S, Siemiatycki J, Shapiro S, Becker R. Health-related information post-discharge: telephone versus face-to-face interviewing. Arch Phys Med Rehabil. 1994;75: 1287-1296.
11. Candelise L, Pinard G, Aritzu E, Musicco M. Telephone interview for stroke outcome assessment. Cerebrovasc Dis. 1994;4:341-343.
12. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 274:1017-1025.
13. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II): Second European-Australian Acute Stroke Study Investigators. Lancet. 1998;17:1245-1251.
14. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC, for the OSF Stroke Team. Treating acute stroke patients with intravenous tPA: the OSF Stroke Network experience. Stroke. 2000;31:77-81.
15. Katzan IL, Furlan AJ, Way LE, Frank JI, Harper DL, Binchey JA, Sila CA. A systematic audit of IV tPA use in Cleveland area hospitals. Stroke. 1999;30:266. Abstract.
16. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospital cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
17. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke: the Framingham Study. Stroke. 1982;13: 290-295.